Key opportunities in the precision oncology market include the rising adoption of personalized therapies, growth in ...

The oncology adjuvants market is expanding due to rising cancer rates, personalized medicine demand, and advances in ...

Attendees will understand how new data unveiled at the European Society for Medical Oncology (ESMO) 2025 annual meeting may influence the future of cancer treatment, including shifts in clinical ...

The 5th Binaytara Precision Oncology Summit, a two-day conference chaired by Dr. Mark Pegram, convenes in San Francisco on October 24-25, 2025. The summit is dedicated to redefining cancer treatment ...

New methods of testing tissue and plasma beyond next-generation sequencing (NGS) could be used to deliver the best ...

Value-based oncology care requires balancing rapid innovation with operational sustainability, equitable access, and ...

According to DataM Intelligence, the Intraoperative Radiation Therapy Market is experiencing rapid technological and clinical adoption, underpinned by the surge in global cancer prevalence and a ...

Rising Cancer Incidence Fuels Demand for Smart Nanomedicine Solutions in Oncology CareThe Smart Cancer Nanomedicine Market ...

Q3 2025 Earnings Call Transcript November 4, 2025 Kura Oncology, Inc. misses on earnings expectations. Reported EPS is ...

An NYC Health + Hospitals/Elmhurst (N.Y). team recently performed the system’s first stereotactic radiosurgery treatment using Varian’s TrueBeam linear accelerator. The hospital’s linear accelerator ...

New Drug Application for ziftomenib in adults with R/R NPM1-m AML remains under FDA Priority Review, with a PDUFA target action date of ...

Dr. Lovly will be division chief of thoracic medical oncology, professor in the Department of Medical Oncology & Therapeutics ...